Cryo-EM structure of the human native plasma coagulation factor XIII complex

S Sneha Singh G Gregor Hagelueken D Deniz Ugurlar (3Materials and Structural Analysis, ThermoFisher Scientific, Eindhoven, The Netherlands) S Samhitha Urs Ramaraje Urs (1Arijit Biswas Laboratory, Institute for Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany) A Amit Sharma M Manoranjan Mahapatra (1AIIMS, New Delhi, Department of Hematology, New Delhi, India) F Friedel Drepper (5Institute of Biology II, University of Freiburg, Freiburg, Germany) D Diana Imhof (6Pharmaceutical Institute, University of Bonn, Bonn, Germany) P Pitter F. Huesgen J Johannes Oldenburg M Matthias Geyer A Arijit Biswas (1Arijit Biswas Laboratory, Institute for Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany)

Abstract

Abstract The structure of human coagulation factor XIII (FXIII), a heterotetrameric plasma protransglutaminase that covalently cross-links preformed fibrin polymers, remains elusive until today. The heterotetrameric complex is composed of 2 catalytic FXIII-A and 2 protective FXIII-B subunits. Structural etiology underlying FXIII deficiency has so far been derived from crystallographic structures, all of which are currently available for the FXIII-A2 homodimer only. Here, we present the cryogenic electron microscopy (cryo-EM) structure of a native, human plasma–derived FXIII-A2B2 complex at 2.4 Å resolution. The structure provides detailed information on FXIII subunit interacting interfaces as the 2 subunits interact strongly in plasma. The native FXIII-A2B2 complex reveals a pseudosymmetric heterotetramer of 2 FXIII-B monomers intercalating with a symmetric FXIII-A2 dimer forming a “crown”-like assembly. The symmetry axes of the A2 and B2 homodimers are twisted relative to each other such that Sushi domain 1 interacts with the catalytic core of the A subunit, and Sushi domain 2 with the symmetry related A′ subunit, and vice versa. We also report 4 novel mutations in the F13A1 gene encoding the FXIII-A subunit from a cohort of patients with severe FXIII deficiency. Our structure reveals the etiological basis of homozygous and heterozygous pathogenic mutations and explains the conditional dominant negative effects of heterozygous mutations. This atomistic description of complex interfaces is consistent with previous biochemical data and shows a congruence between the structural biochemistry of the FXIII complex and the clinical features of FXIII deficiency.

Article Details

Journal Blood
Volume / Issue Vol. 145, Issue 4
Published January 23, 2025
Pages 438-449
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (12)

S

Sneha Singh

G

Gregor Hagelueken

D

Deniz Ugurlar

3Materials and Structural Analysis, ThermoFisher Scientific, Eindhoven, The Netherlands

S

Samhitha Urs Ramaraje Urs

1Arijit Biswas Laboratory, Institute for Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany

A

Amit Sharma

M

Manoranjan Mahapatra

1AIIMS, New Delhi, Department of Hematology, New Delhi, India

F

Friedel Drepper

5Institute of Biology II, University of Freiburg, Freiburg, Germany

D

Diana Imhof

6Pharmaceutical Institute, University of Bonn, Bonn, Germany

P

Pitter F. Huesgen

J

Johannes Oldenburg

M

Matthias Geyer

A

Arijit Biswas

1Arijit Biswas Laboratory, Institute for Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany